A/Prof Seetal Dodd

Find out more about Seetal Dodd's experience

Seetal Dodd's highlights

FEATURED Journal article

Physical Activity as a Predictor of Clinical Trial Outcomes in Bipolar Depression: A Subanalysis of a Mitochondrial-Enhancing Nutraceutical Randomized Controlled Trial

Seetal Dodd's selected work

The Vital D Study - Mental Health Substudy

Research Grant

ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and..

Journal article

The Link Between Depression And Osteoporosis.

Research Grant

Diet quality, dietary inflammatory index and body mass index as predictors of response to ..

Journal article

A Randomised Trial Of Internet Based Interventions For Bipolar Disorder

Research Contracts

Does N-acetylcysteine improve behaviour in children with autism?: A mixed-methods analysis..

Projects

Displaying the 3 most recent projects by Seetal Dodd.

The Vital D Study - Mental Health Substudy

Vitamin D is commonly deficient in Western populations, more so in the winter months and in the elderly. A link between depression and vitam..

2008 - 2008

Completed

The Link Between Depression And Osteoporosis.

Both depression and osteoporosis are common, debilitating and expensive diseases and there is research to suggest that these conditions are ..

2008 - 2010

Completed

A Randomised Trial Of Internet Based Interventions For Bipolar Disorder

Completed

3

Projects

Project Types

Research Grant

Research Contracts

Scholarly Works

Displaying the 249 most recent scholarly works by Seetal Dodd.

Physical Activity as a Predictor of Clinical Trial Outcomes in Bipolar Depression: A Subanalysis of a Mitochondrial-Enhancing Nutraceutical Randomized Controlled Trial

Melanie M Ashton, Mohammadreza Mohebbi, Alyna Turner, Wolfgang Marx, Michael Berk, Gin S Malhi, Chee H Ng, Sue M Cotton, Seetal Dodd, Jerome Sarris, Malcolm Hopwood, Brendon Stubbs, Olivia M Dean

Journal article | 2019 | The Canadian Journal of Psychiatry

OBJECTIVES: Individuals with bipolar disorder (BD) generally engage in low levels of physical activity (PA), and yet few studies h..

ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis

SM Cotton, M Berk, A Watson, S Wood, K Allott, CF Bartholomeusz, CC Bortolasci, K Walder, B O'Donoghue, OM Dean, A Chanen, GP Amminger, PD McGorry, A Burnside, J Uren, A Ratheesh, S Dodd

Journal article | 2019 | Trials

BACKGROUND: First-episode psychosis (FEP) may lead to a progressive, potentially disabling and lifelong chronic illness; however, ..

Diet quality, dietary inflammatory index and body mass index as predictors of response to adjunctive N-acetylcysteine and mitochondrial agents in adults with bipolar disorder: A sub-study of a randomised placebo-controlled trial

Melanie M Ashton, Olivia M Dean, Wolfgang Marx, Mohammadreza Mohebbi, Michael Berk, Gin S Malhi, Chee H Ng, Sue M Cotton, Seetal Dodd, Jerome Sarris, Malcolm Hopwood, Keshav Faye-Chauhan, Yesul Kim, Sarah R Dash, Felice N Jacka, Nitin Shivappa, James R Hebert, Alyna Turner

Journal article | 2019 | Australian & New Zealand Journal of Psychiatry

AIMS: We aimed to explore the relationships between diet quality, dietary inflammatory potential or body mass index and outcomes o..

Does N-acetylcysteine improve behaviour in children with autism?: A mixed-methods analysis of the effects of N-acetylcysteine

Olivia M Dean, Kylie Gray, Seetal Dodd, Kristi-Ann Villagonzalo, Ellie Brown, Bruce Tonge, Michael Berk, Linda K Byrne

Journal article | 2019 | Journal of Intellectual & Developmental Disability

Putative neuroprotective pharmacotherapies to target the staged progression of mental illness

Oliver D Robertson, Nieves G Coronado, Rickinder Sethi, Michael Berk, Seetal Dodd

Journal article | 2019 | Early Intervention in Psychiatry

AIM: Neuropsychiatric disorders including depression, bipolar and schizophrenia frequently exhibit a neuroprogressive course from ..

N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial

Lauren Arancini, Chiara C Bortolasci, Seetal Dodd, Olivia M Dean, Michael Berk

Journal article | 2019 | Trials

Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders

Rickinder Sethi, Nieves Gomez-Coronado, Adam J Walker, Oliver D'Arcy Robertson, Bruno Agustini, Michael Berk, Seetal Dodd

Journal article | 2019 | Frontiers in Psychiatry

Association between solar insolation and a history of suicide attempts in bipolar I disorder

Michael Bauer, Tasha Glenn, Martin Alda, Ole A Andreassen, Elias Angelopoulos, Raffaella Ardau, Yavuz Ayhan, Christopher Baethge, Rita Bauer, Bernhard T Baune, Claudia Becerra-Palars, Frank Bellivier, Robert H Belmaker, Michael Berk, Yuly Bersudsky, Sule Bicakci, Harriet Birabwa-Oketcho, Thomas D Bjella, Jorge Cabrera, Eric Y Wo Cheung, et al.

Journal article | 2019 | Journal of Psychiatric Research

Efficacy of adjunctive Garcinia mangostana Linn (mangosteen) pericarp for bipolar depression: study protocol for a proof-of-concept trial

Melanie M Ashton, Michael Berk, Chee H Ng, Malcolm Hopwood, Seetal Dodd, Alyna Turner, Ellie Brown, Felice N Jacka, Susan M Cotton, Jon-Paul Khoo, Mary Lou Chatterton, Bianca E Kavanagh, Sarah E Nadjidai, Samantha L Lo Monaco, Brian H Harvey, Jerome Sarris, Gin S Malhi, Nathan L Dowling, Olivia M Dean

Journal article | 2019 | Brazilian Journal of Psychiatry

Protocol and Rationale: A 24-week Double-blind, Randomized, Placebo Controlled Trial of the Efficacy of Adjunctive Garcinia mangostana Linn. (Mangosteen) Pericarp for Schizophrenia

Alyna Turner, John J McGrath, Olivia M Dean, Seetal Dodd, Andrea Baker, Susan M Cotton, James G Scott, Bianca E Kavanagh, Melanie M Ashton, Adam J Walker, Ellie Brown, Michael Berk

Journal article | 2019 | Clinical Psychopharmacology and Neuroscience

The Therapeutic Potential of Mangosteen Pericarp as an Adjunctive Therapy for Bipolar Disorder and Schizophrenia

Melanie M Ashton, Olivia M Dean, Adam J Walker, Chiara C Bortolasci, Chee H Ng, Malcolm Hopwood, Brian H Harvey, Marisa Moller, John J McGrath, Wolfgang Marx, Alyna Turner, Seetal Dodd, James G Scott, Jon-Paul Khoo, Ken Walder, Jerome Sarris, Michael Berk

Journal article | 2019 | Frontiers in Psychiatry

Youth depression alleviation with anti-inflammatory agents (YoDA-A): A placebo-controlled randomised augmentation trial of rosuvastatin and aspirin

M Berk, M Mohammadreza, OM Dean, SM Cotton, AM Chanen, S Dodd, A Ratheesh, GP Amminger, M Phelan, A Williams, A Mackinnon, F Giorlando, S Baird, S Rice, M O'Shea, MR Schafer, E Mullen, S Hetrick, M Kerr, SM Harrigan, et al.